森基努化物I通过恢复突触可塑性来挽救辐射引起的认知缺陷
Feiyan Li1, Yuan Xu1, Shun Guo1
1Department of Pharmacy, Tangdu Hospital, the Fourth Military Medical University, Xi'an 710038 Shaanxi, China.
Brain research
|October 24, 2025
概括
森基努化物I (SI) 通过减少氧化应激和炎症,有效地逆转了小鼠的辐射诱导的认知缺陷. 这种化合物还改善了突触功能和神经元完整性,为放射治疗患者提供了潜在的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 放射治疗研究 放射治疗研究
- 药理学 药理学是指药理学的学科.
背景情况:
- 辐射诱导的认知缺陷 (RICD) 是放射治疗后的一个重大临床挑战.
- RICD与突触可塑性受损,氧化应激和神经炎症有关.
研究的目的:
- 为了研究森基努化物I (SI) 在预防或逆转RICD方面的潜力.
- 阐明SI对辐射诱导的大脑损伤影响的潜在机械路径.
主要方法:
- 成年雄性C57BL/6小鼠接受了分成的头骨辐射.
- 小鼠接受了不同剂量的SI的腹腔内注射.
- 用行为测试,电生理学,尼斯尔染色和生物化学测试来评估认知功能,突触完整性,神经元密度和分子标记.
主要成果:
- 在莫里斯水迷宫和新型物体识别测试中,SI治疗显著改善了认知表现.
- 电生理学研究表明,海马长期潜能 (LTP) 的部分恢复以及关键突触蛋白降低调节的逆转.
- 通过增加SOD和GSH-Px活动和降低MDA水平,SI显示出抗氧化作用,同时通过抑制TNF-α和IL-6和恢复BDNF水平,也表现出抗炎性质.
结论:
- 森基努诺化物I通过抗氧化,抗炎,神经营养和突触保护机制的组合有效地减轻辐射诱导的认知缺陷.
- 这些临床前发现表明SI是RICD的有希望的治疗剂,需要进一步的临床研究.
相关概念视频
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
552
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
552
01:03Long-term Depression
3.1K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
3.1K